PMC:7402624 / 334-472
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 86-90 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T2 | 97-101 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 14 | 129-137 | Species | denotes | patients | Tax:9606 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 70-80 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
| T5 | 84-90 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cell |
| T6 | 95-101 | http://purl.obolibrary.org/obo/CL_0000236 | denotes | B cell |
| T7 | 113-114 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 0-138 | Sentence | denotes | Integrated analysis of ~200 immune and ~50 clinical features revealed activation of T cell and B cell subsets in a proportion of patients. |